Drug profile · INN
probucol
LORELCO
probucol (LORELCO) is a atp-binding cassette sub-family a member 1 inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — probucol
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
probucol (LORELCO) is a atp-binding cassette sub-family a member 1 inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
ATP-binding cassette sub-family A member 1 inhibitor
Primary target: Phospholipid-transporting ATPase ABCA1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is probucol?
probucol (LORELCO) is a atp-binding cassette sub-family a member 1 inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for probucol?
LORELCO is a marketed brand name for probucol. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of probucol?
probucol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.